StockData
Kairos Pharma, LTD. logo

Kairos Pharma, LTD. (KAPA) stock

KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.44+0.04 (+10.08%)

Close on Nov 18, 2026Market cap $1.64MP/E –Yield –

Kairos Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Kairos Pharma's enterprise value was $8.30M on Nov 11, 2026, against $115.93M a year earlier. Over the last 2 years it ranged from $8.30M to $164.64M, with a median of $88.75M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$8.30M-91.5%
2025Dec 31, 2025$97.91M-26.6%
2024Dec 31, 2024$133.47M–

More Kairos Pharma figures

See a number that looks wrong?